Ad26.COV2.S priming provides a solid immunological base for mRNA-based COVID-19 booster vaccination

NCATS Open Data2022-07-22 更新2026-08-08 收录

流感疫苗免疫原性

异源加强接种策略

数据链接：

https://doi.org/10.1101/2022.07.15.22277639 数据链接链接失效反馈

官方服务：

资源简介：

Ad26.COV2.S priming provides a solid immunological base for mRNA-based COVID-19 booster vaccination

创建时间：

2022-07-18

DataSheet_3_Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children: Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 Trial.pdf

COVID-19疫苗免疫评估

流感疫苗免疫原性

Safe and effective vaccines against SARS-CoV-2 for children are urgently needed. Here we aimed to assess the safety and immunogenicity of an inactivated COVID-19 vaccine candidate, WIBP-CorV, in parti

NIAID Data Ecosystem50

Characteristics of the study groups.

流感疫苗免疫原性

支气管肺疾病临床研究

Influenza is especially dangerous for high-risk patients, for whom various vaccination strategies are used to prevent this disease. This study assessed the safety and immunological effectiveness of an

Figshare2025-09-18 更新20

Correlation between overall and influenza-specific humoral immune response variables following influenza vaccination.

流感疫苗免疫原性

免疫应答分析

aSpearman’s rank r bOnly correlations with p-values below or equal to 0.05 are presented cInfluenza A/H1N1-specific memory-like IgG B cell ELISPOT response Correlation between overall and influenza-sp

NIAID Data Ecosystem10

Vaccination with drifted variants of H5 hemagglutinin protein elicits a broadened antibody response

流感疫苗免疫原性

抗原漂移抗体应答

Assess the humoral response of mice immunized with drifted variant H5 hemagglutinin proteins

Immunology Database and Analysis Portal2025-10-30 更新20

Immunogenicity and Reactogenicity of Fractional vs. Full Booster Doses of COVID-19 Vaccines: A Non-Inferiority, Randomized, Double-Blind, Phase IV Clinical Trial in Pakistan

流感疫苗免疫原性

疫苗剂量优化

Background: Vaccine dose fractionation has been explored as a potential dose-sparing strategy to expand vaccine access. We conducted a randomized controlled trial to evaluate the immunogenicity and sa

DataCite Commons2025-07-07 更新20

Ad26.COV2.S priming provides a solid immunological base for mRNA-based COVID-19 booster vaccination

资源简介：

相关数据集